PURPOSE: Many community cancer clinics closed between 2008 and 2016, with additional closings potentially expected. Limited data exist on the impact of travel time on health care costs and resource use. METHODS: This retrospective cohort study (2012 to 2015) evaluated travel time to cancer care site for Medicare beneficiaries age 65 years or older in the southeastern United States. The primary outcome was Medicare spending by phase of care (ie, initial, survivorship, end of life). Secondary outcomes included patient cost responsibility and resource use measured by hospitalization rates, intensive care unit admissions, and chemotherapy-related hospitalization rates. Hierarchical linear models with patients clustered within cancer care site (CCS) were used to determine the effects of travel time on average monthly phase-specific Medicare spending and patient cost responsibility. RESULTS: Median travel time was 32 (interquartile range, 18-59) minutes for the 23,382 included Medicare beneficiaries, with 24% of patients traveling longer than 1 hour to their CCS. During the initial phase of care, Medicare spending was 14% higher and patient cost responsibility was 10% higher for patients traveling longer than 1 hour than those traveling 30 minutes or less. Hospitalization rates were 4% to 13% higher for patients traveling longer than 1 hour versus 30 minutes or less in the initial (61 v 54), survivorship (27 v 26), and end-of-life (310 v 286) phases of care (all P < .05). Most patients traveling longer than 1 hour were hospitalized at a local hospital rather than at their CCS, whereas the converse was true for patients traveling 30 minutes or less. CONCLUSION: As health care locations close, patients living farther from treatment sites may experience more limited access to care, and health care spending could increase for patients and Medicare.
PURPOSE: Many community cancer clinics closed between 2008 and 2016, with additional closings potentially expected. Limited data exist on the impact of travel time on health care costs and resource use. METHODS: This retrospective cohort study (2012 to 2015) evaluated travel time to cancer care site for Medicare beneficiaries age 65 years or older in the southeastern United States. The primary outcome was Medicare spending by phase of care (ie, initial, survivorship, end of life). Secondary outcomes included patient cost responsibility and resource use measured by hospitalization rates, intensive care unit admissions, and chemotherapy-related hospitalization rates. Hierarchical linear models with patientsclustered within cancer care site (CCS) were used to determine the effects of travel time on average monthly phase-specific Medicare spending and patient cost responsibility. RESULTS: Median travel time was 32 (interquartile range, 18-59) minutes for the 23,382 included Medicare beneficiaries, with 24% of patients traveling longer than 1 hour to their CCS. During the initial phase of care, Medicare spending was 14% higher and patient cost responsibility was 10% higher for patients traveling longer than 1 hour than those traveling 30 minutes or less. Hospitalization rates were 4% to 13% higher for patients traveling longer than 1 hour versus 30 minutes or less in the initial (61 v 54), survivorship (27 v 26), and end-of-life (310 v 286) phases of care (all P < .05). Most patients traveling longer than 1 hour were hospitalized at a local hospital rather than at their CCS, whereas the converse was true for patients traveling 30 minutes or less. CONCLUSION: As health care locations close, patients living farther from treatment sites may experience more limited access to care, and health care spending could increase for patients and Medicare.
Authors: Gabrielle B Rocque; Edward E Partridge; Maria Pisu; Michelle Y Martin; Wendy Demark-Wahnefried; Aras Acemgil; Kelly Kenzik; Elizabeth A Kvale; Karen Meneses; Xuelin Li; Yufeng Li; Karina I Halilova; Bradford E Jackson; Carol Chambless; Nedra Lisovicz; Mona Fouad; Richard A Taylor Journal: J Oncol Pract Date: 2016-05-10 Impact factor: 3.840
Authors: Gabrielle B Rocque; Richard A Taylor; Aras Acemgil; Xuelin Li; Maria Pisu; Kelly Kenzik; Bradford E Jackson; Karina I Halilova; Wendy Demark-Wahnefried; Karen Meneses; Yufeng Li; Michelle Y Martin; Carol Chambless; Nedra Lisovicz; Mona Fouad; Edward E Partridge; Elizabeth A Kvale Journal: J Natl Compr Canc Netw Date: 2016-04 Impact factor: 11.908
Authors: Ali H Mokdad; Laura Dwyer-Lindgren; Christina Fitzmaurice; Rebecca W Stubbs; Amelia Bertozzi-Villa; Chloe Morozoff; Raghid Charara; Christine Allen; Mohsen Naghavi; Christopher J L Murray Journal: JAMA Date: 2017-01-24 Impact factor: 56.272
Authors: Paul D Colavita; Victor B Tsirline; Igor Belyansky; Ryan Z Swan; Amanda L Walters; Amy E Lincourt; David A Iannitti; B Todd Heniford Journal: J Gastrointest Surg Date: 2014-01-16 Impact factor: 3.452
Authors: Stephanie B Wheeler; William R Carpenter; Jeffrey Peppercorn; Anna P Schenck; Morris Weinberger; Andrea K Biddle Journal: Breast Cancer Res Treat Date: 2011-08-13 Impact factor: 4.872
Authors: Aaron T Seaman; Kristen L Seligman; Khanh K Nguyen; Zaid Al-Qurayshi; Nicholas D Kendell; Nitin A Pagedar Journal: Cancer Date: 2021-08-30 Impact factor: 6.860
Authors: Courtney P Williams; Amy Davidoff; Michael T Halpern; Michelle Mollica; Kathleen Castro; Benjamin Allaire; Janet S de Moor Journal: JCO Oncol Pract Date: 2022-08
Authors: Katherine A Yeager; Whitney E Zahnd; Jan M Eberth; Robin C Vanderpool; Catherine Rohweder; Randall Teal; Maihan Vu; Lindsay Stradtman; Elizabeth L Frost; Erika Trapl; Sarah Koopman Gonzalez; Thuy Vu; Linda K Ko; Allison Cole; Paige E Farris; Jackilen Shannon; Natoshia Askelson; Laura Seegmiller; Arica White; Jean Edward; Melinda Davis; Victoria Petermann; Stephanie B Wheeler Journal: J Cancer Surviv Date: 2022-01-26 Impact factor: 4.062
Authors: Zachary A K Frosch; Esin C Namoglu; Nandita Mitra; Daniel J Landsburg; Sunita D Nasta; Justin E Bekelman; Raghuram Iyengar; Carmen E Guerra; Marilyn M Schapira Journal: JCO Oncol Pract Date: 2021-09-15
Authors: Flora Yan; Dylan A Levy; Chun-Che Wen; Cathy L Melvin; Marvella E Ford; Paul J Nietert; Phayvanh P Pecha Journal: Otolaryngol Head Neck Surg Date: 2021-03-02 Impact factor: 5.591
Authors: Kelly R Pekala; Jonathan G Yabes; Jathin Bandari; Michelle Yu; Benjamin J Davies; Lindsay M Sabik; Jeremy M Kahn; Bruce L Jacobs Journal: Urol Oncol Date: 2021-06-20 Impact factor: 3.498
Authors: Gabrielle B Rocque; Courtney P Williams; Stacey A Ingram; Andres Azuero; Stephen T Mennemeyer; Jennifer Young Pierce; Ryan D Nipp; Katherine E Reeder-Hayes; Kelly M Kenzik Journal: Cancer Med Date: 2020-09-21 Impact factor: 4.452